Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 01/24/24 07:05:00 on US and Canada Markets.
Fourth Quarter Highlights Net income of $18.4 million , or $0.58 per diluted share; return on average assets (ROAA) of 1.46% ; return on average stockholders' equity (ROAE) of 15.68% ; and return on average tangible common equity (ROATCE) (1) ...
– Funding from existing investors, including EcoR1 Capital, an affiliate of Deerfield Management and Suvretta Capital – – Pro forma cash, cash equivalents and investments expected to provide runway into 2027 – – Management to host virtual investor even...
TAMPA BAY, FL / ACCESSWIRE / January 24, 2024 / Atlantic Power & Infrastructure Corp's (OTC PINK:AWSL) Next Generation Agriculture division (NGAG) has secured a groundbreaking partnership with Silvanus Forestry, Hungary's premier propagators of Black Locust trees for industrial timber and bi...
TORONTO and KNOXVILLE, Tenn., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR) , a leading solar energy solutions provider focused on the commercial and industrial solar sector, is pleased to provide a c...
CHICAGO and VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries ...
APATITE (PHOSPHATE) ADDED TO THE QUEBEC CRITICAL AND STRATEGIC MINERALS LIST Canada NewsWire -announcement will put Arianne Phosphate's Lac à Paul project in focus DAN: TSX-V ( Canada ) JE9N: FSE ( Germany ) DRRSF: OTCQX ( USA ) SAG...
FDA requesting clarifications around chemistry, manufacturing and controls and additional information related to immunogenicity CRL does not impact commercial availability of EGRIFTA SV ® , the F4 formulation of tesamorelin, the only medication approved in the U.S. ...
COEUR D'ALENE, ID / ACCESSWIRE / January 24, 2024 / Idaho Strategic Resources (AMEX:IDR) ("IDR" or the "Company") is pleased to announce that its CEO and President, John Swallow has been invited by members from the U.S. Department of Energy (DoE) to speak at the upcoming workshop titled Future I...
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases' Canada NewsWire Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to 'a world free from all diseases and future pandemics' Digitally en...
FDA requesting clarifications around chemistry, manufacturing and controls and additional information related to immunogenicity CRL does not impact commercial availability of EGRIFTA SV ® , the F4 formulation of tesamorelin, the only medication approved in the U.S. ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
19.51%Change Percent:
TrueBlue Inc. Company Name:
TBI Stock Symbol:
NYSE Market:
trueblue.com Website: